Ryugasaki, Japan

Michiko Kawamoto



 

Average Co-Inventor Count = 4.1

ph-index = 1


Location History:

  • Ibaraki, JP (2013)
  • Ryugasaki, JP (2008 - 2015)
  • Tokyo, JP (2020)

Company Filing History:


Years Active: 2008-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michiko Kawamoto: Innovator in Immunoassay Technology

Introduction

Michiko Kawamoto is a prominent inventor based in Ryugasaki, Japan. She has made significant contributions to the field of immunoassay technology, holding a total of 5 patents. Her work focuses on developing methods that enhance the sensitivity and specificity of assays, particularly in the detection of antibodies.

Latest Patents

One of her latest patents is for a latex agglutination inhibition immunoassay. This invention addresses the challenge of nonspecific reactions that can lead to false negatives in agglutination tests. The method involves using specific compounds to minimize these nonspecific reactions, thereby improving the reliability of the test results. Another notable patent is a reagent for assaying anti-treponema pallidum antibody. This reagent is designed to provide high assay sensitivity and specificity by utilizing a recombinant polypeptide as an antigen, which enhances the accuracy of the antibody detection.

Career Highlights

Throughout her career, Michiko has worked with notable companies such as Sekisui Medical Co., Ltd. and Japan Lamb Inc. Her experience in these organizations has allowed her to refine her skills and contribute to advancements in medical diagnostics.

Collaborations

She has collaborated with esteemed colleagues, including Yasuyuki Hara and Koji Ushizawa, to further her research and development efforts in immunoassay technologies.

Conclusion

Michiko Kawamoto's innovative work in immunoassay technology has significantly impacted the field of medical diagnostics. Her patents reflect her commitment to improving assay methods, making her a valuable contributor to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…